Skip to main content
Jean-Raphaël Champagne Avocat/Associate Québec

Jean-Raphaël Champagne

Partner Fasken
The marijuana bill regulate several aspects of the market, including the types of products that can be sold and the scope of acceptable promotional initiatives.
Jurisdiction Québec, 2013
Language(s) French, English
Office(s) Québec City
Contact
Share
  • LinkedIn

Overview

Jean-Raphaël Champagne advises clients on issues related to commercial, regulatory and competition law. He assists a wide variety of players in the technology and life sciences sectors. He has extensive experience drafting and reviewing contracts, with respect to regulatory compliance with Health Canada and the rules governing clinical trials, research and ethical standards applicable to the pharmaceutical and medtech industries. He also counsels' clients on cannabis-related issues.

Jean-Raphaël advises clients on the complex regulatory framework applicable to patient support programs in Canada. He is often called upon to provide legal input on market access strategies and solve pricing and reimbursement questions.

He also assists clients with strategic aspects and issues arising from competition law.

He has participated in many start-ups in several high-technology sectors. Jean-Raphaël has also led several major licensing deals as well as purchase and sale transactions involving private financings and technology transfers. 

He is co-author of "The Pharma Legal Handbook – Canada".

Achievements

Experience

  • Harnois Énergies and Michaud Petroleum get the green light from the Competition Bureau of Canada for the creation of Michaud Harnois Énergies, [Deal - Harnois Énergies Inc.], Harnois Énergies and Michaud Petroleum receive approval from the Competition Bureau of Canada to create the joint venture Michaud Harnois Énergies operating in New Brunswick.
  • Acquisition of Airmedic by Dessercom, [Deal - Dessercom], Advised Dessercom in the acquisition of Airmedic, a leader in emergency air medical transport.
  • Functionalab completes merger with FYi Medical Aesthetics, creating the largest network of premium aesthetic medicine clinics in Canada, [Deal - Functionalab Inc.], Merger leading to the creation of the largest network of premium aesthetic medicine clinics in Canada.
  • Advent International acquires leading specialty chemicals solutions provider Caldic from Goldman Sachs Asset Management, [Deal - Advent International], Advent International is one of the largest and most experienced global private equity investors.
  • Pétroles Cadeko Inc. acquired 184 service stations, 98 of which operate under the Petro-Canada banner and 86 under the Eko, Sonerco and Axco banners, [Deal - Pétroles Cadeko Inc.], Representation of the purchaser in connection with the acquisition of 184 service stations.
  • GenePOC reaches an agreement with Meridian Bioscience for the acquisition of its molecular diagnostics business, [Deal - GenePOC Inc], On June 3, 2019, GenePOC, a Debiopharm Group company, concluded the sale of its molecular diagnostics business to Meridian Bioscience. The purchase price for GenePOC’s molecular business has a maximum potential value of $120M US, with $50M US paid at closing (subject to a holdback and working cap...
  • Cambrex Corporation acquires Halo Pharmaceuticals for US$425 million, [Deal - Cambrex Corporation], Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), acquired Halo Pharma, a leading dosage form Contract Development and Manufacturing Organization (CDMO) located in Whippany, New Jersey and Mirabel, Québec, Can...
  • Assisting a pharmaceutical manufacturer manage advertising complaints before PAAB and Health Canada, [Deal - Confidential Client], Fasken was retained by a pharmaceutical manufacturer to assist with advertising complaints across multiple adjudicative structures, including, Health Canada and the Pharmaceutical Advertising Advisory Board (PAAB).    Fasken team was composed of Mathieu Gagné, Jean-Raphaël Champagne and Dara Jo...
  • Representing a global medical device manufacture in connection with a recall by Health Canada, [Deal - Confidential Client], Fasken was retained by a major global manufacturer with various aspects relating to a Type II recall by Health Canada of its medical device (in Canada and the U.S.).As a result of Fasken’s guidance, the company was able to continue to commercialize their medical devices throughout the recall proc...

Career & Education

Education

  • MSc, Molecular biology and Law University of Sherbrooke
  • PDDB, with major in Finance Vancouver Island University
  • LLB, Life Science University of Sherbrooke

Knowledge

  • Ontario Moves to Regulate Preferred Pharmacy Networks (PPNs), 11/11/2025
  • Important Changes To The Exception Patient Measure In Quebec, 7/24/2025
  • Health Canada's New Draft Guidance for Biosimilar Biologic Drugs, 6/24/2025
  • Pharma and Device Compliance in Canada 2024 - 2025 Year In Review, 6/5/2025
  • Pre-Market Considerations for Machine Learning-Enabled Medical Devices, 3/19/2025
  • Proposed Regulations to Mitigate Drug and Device Shortages in Canada, 2/28/2025
  • Pharma and Device Compliance in Canada 2023 - 2024 Year In Review, 7/30/2024
  • Fast-Tracked Approval for Medical Devices: Health Canada Expands Urgent Public Health Considerations Beyond COVID-19, 1/25/2024
  • U.S. Importation of Drugs: Navigating the Impact on Canadian Drug Supply, 1/17/2024
  • PAAB Revisions: Real-World Evidence in Advertising, 1/15/2024

Events

  • Cannabis Law Webinar Series: Psychedelics, 9/14/2021
  • Cannabis industry: the situation as it stands in the lead-up to the legislation, 5/18/2018
  • Seminar on the issues related to legalizing marijuana, 11/15/2017
  • Product Listing Agreements (PLA) in Québec : Where are we at?, 10/14/2015

News

  • Fasken Will Be at the Pharma & MedTech Compliance Conference in Toronto, 5/25/2026
  • Fasken will be at the Pharma & MedTech Compliance Conference in Toronto, 4/30/2025
  • Fasken Adds 21 New Partners, 1/16/2020
  • Fasken Recognized at the LMG Life Sciences Awards, 9/26/2019
  • Radio-Canada interviews Jean-Raphaël Champagne in a report on the legalization and regulation of cannabis, 10/3/2018
  • Radio-Canada interviews Jean-Raphaël Champagne about the legalization of cannabis and the municipal regulation, 10/3/2018
  • Ici.Radio-Canada.ca interviews Jean-Raphaël Champagne in a report on a search at a cannabis shop, 10/10/2017
  • Téléjournal RDI - Québec interviews Jean-Raphaël Champagne in a report on the parameters of selling marijuana, 3/27/2017
  • Ici.Radio-Canada.ca quotes Jean-Raphaël Champagne in an article on the legality of selling cannabis on the web, 1/27/2017
  • Radio-Canada cet après-midi interviews Jean-Raphaël Champagne in a report on a new medical cannabis clinic in Québec City, 10/27/2016

Publications

  • Space Law 2024 : Trends and Developments, 7/11/2024
  • Health Canada revising medical device premarket guidance framework in response to evolving AI, 11/24/2023
  • When is Software a Medical Device?, 5/17/2019
  • The Future of Cannabis and Cosmetics in Canada, 4/24/2019
  • The Pharma Legal Handbook - Canada, 12/5/2018
  • Life Line, 6/23/2015
  • Life Line, 12/22/2014
  • Life Line, 12/12/2013
  • Au revoir au système « first-to-invent » aux États-Unis, 4/12/2013
  • Le brevet du Viagra frappé de nullité, 11/20/2012

Speaking Engagements

  • Cannabis: prohibition; légalisation; réglementation (Available in French only), 10/28/2021
  • Cannabis Advertising: What You Need to Know, 6/21/2019
  • Amendements au projet de loi 2 concernant le resserrement de la loi encadrant le cannabis, 5/14/2019
  • Nouveaux administrateurs : Les aspects légaux à votre portée, 11/29/2013
  • Introduction to pharmaceutical law, 11/27/2012